LTI-291

LTI-291 is the first small-molecule activator of Glucocerebrosidase(GCase) for the treatment of parkinson’s disease.

Price Not Available 25mg LTI-291 Supplier Page
Trivial name N/A
Catalog Number S1024
Molecular Formula C13H16N2O4
CAS# 1919820-28-2
Inchi InChI=1S/C13H16N2O4/c14-11(16)7-6-10(13(18)19)15-12(17)8-9-4-2-1-3-5-9/h1-5,10H,6-8H2,(H2,14,16)(H,15,17)(H,18,19)/t10-/m0/s1
Inchi Key JFLIEFSWGNOPJJ-JTQLQIEISA-N
SMILES C1=CC=C(C=C1)CC(=O)NC(CCC(=O)N)C(=O)O
Size 25mg
Supplier Page http://www.selleckchem.com/products/lti-291.html
Additional Information https://file.selleck.cn/downloads/struct/lti-291-chemical-structure-s1024.gif